SIGNIFICANTLY STRONG EXPRESSION  OF STAT6 AND SSTR2A IN DIFFERENTIATE THE SOLITARY FIBROUS TUMOR / HEMANGIOPERICYTOMA (SFT/HPC)  AND MENINGIOMA

bela bagus setiawan

doi:10.30649/obj.v6i1.99

Penulis

bela bagus setiawan Fakultas kedokteran universitas diponegoro/RSUP dr kariadi

DOI:

https://doi.org/10.30649/obj.v6i1.99

Kata Kunci:

Meningeal solitary fibrous tumor (SFT)/hemangiopericytoma (HPC), Meningioma, STAT6, SSTR2A

Abstrak

Background: Solitary fibrous tumor / hemangiopericytoma (SFT / HPC) and fibroblastic types of meningioma have similarities that is difficult to distinguish based on histology. Immunohistochemistry of STAT6 and SSTR2A are definitive biomarkers in both tumors. Inversion-mediated fusions between two genes, NAB2 and STAT6, were detected in SFT / HPC that inducES proliferation in cells. The somatostatin receptor (SSTR) 2 is located on chromosome 17q25.1 which is expressed diffusely in meningiomas.

Objective: This study aimed to determine the expression of STAT6 and SSTR2A in SFT/HPC and meningiomas.

Methods: An analytical observational study with consecutive sampling on 64 samples diagnosed with SFT/HPC and meningioma. Samples divided into 3 groups, group 1 consisted of grade I meningoma, group 2 consisted of grade II and III meningioma and group 3 consisted of solitary fibrous tumor/Hemangiopericytoma (SFT/HPC).

Results: Based on the Mann Withney comparative test, STAT6 expressions showed significant differences in group 1 and 3, as well as group 2 and 3 (P < 0.05). SSTR2A expressions in group 1 and 3, as well as group 2 and 3 also showed significant differences (P < 0.05).

Conclusion: Immunohistochemistry of STAT6 and SSTR2A is strongly expressed in SFT/HPC and meningioma.

Keywords: Meningeal solitary fibrous tumor (SFT)/hemangiopericytoma (HPC), Meningioma, STAT6, SSTR2A.

Referensi

Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-820. doi:10.1007/s00401-016-1545-1

Boyett D, Kinslow CJ, Bruce SS, et al. Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system. J Neurooncol. 2019;143(3):457-464. doi:10.1007/s11060-019-03177-0

T. Ratneswaren, F. Hogg, M. J. Gallagher KA. Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease. J Neurooncol. 2018;138(3):447-467.

Yuzawa S, Nishihara H, Wang L, et al. Analysis of NAB2-STAT6 Gene Fusion in 17 Cases of Meningeal Solitary Fibrous Tumor/Hemangiopericytoma: Review of the Literature. Am J Surg Pathol. 2016;40(8):1031-1040.

Hammouche S, Clark S, Wong AHL, Eldridge P, Farah JO. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir. 2014;156(8):1475-1481.

Fodi C, Skardelly M, Hempel JM, et al. The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma. Neurosurg Rev. 2022;45(4):2671-2679. doi:10.1007/s10143-021-01651-w

Fritchie K, Jensch K, Moskalev EA, et al. The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma. Acta Neuropathol. 2019;137(2):307-319.

Anis SE, Lotfalla M, Zain M, Kamel NN, Soliman AA. Value of SSTR2A and claudin-1 in differentiating meningioma from schwannoma and hemangiopericytoma. Open Access Maced J Med Sci. 2018;6(2):248-253. doi:10.3889/OAMJMS.2018.062

V. Barresi, C. Alafaci, F. Salpietro GT. Sstr2A immunohistochemical expression in human meningiomas: Is there a correlation with the histological grade, proliferation or microvessel density? Oncol Rep. 2008;20:485-492.

Siregar, Nurjati Chairani, Angelina A, Tarigan IN. Solitary Fibrous Tumor: a Retrospective Study on Histopathologic Features and Immunohistochemistry Staining at Cipto Mangunkusumo Hospital. eJournal Kedokt Indones. 2018;6(2).

Quinn T Ostrom, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019;21(5):1-100.

Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3). doi:10.3390/biomedicines9030319

Endo T, Ali H, Murakami K, Narisawa A. A study of prognostic factors in 45 cases of atypical meningioma. Acta Neurochir (Wien). 2016;158(9).

Barthelmeß S, Geddert H, Boltze C, et al. Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol. 2014;184(4):1209-1218.

Yamashita D, Suehiro S, Kohno S, et al. Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis. Neurosurg Rev. 2021;44(3):1591-1600. doi:10.1007/s10143-020-01348-6